Usage (hours) | Obesity hypoventilation syndrome | 7.6 | 4.9 |
Neuromuscular disease | 9.2 | 4 |
Restrictive chest wall disease | 8.9 | 1.3 |
Obstructive lung disease | 9.2 | 5.6 |
Total leak (L/min) | Obesity hypoventilation syndrome | 51 | 39 |
Neuromuscular disease | 55 | 35 |
Restrictive chest wall disease | 41 | 13 |
Obstructive lung disease | 38 | 18 |
Unintentional leak (L/min) | Obesity hypoventilation syndrome | 11 | 22 |
Neuromuscular disease | 9 | 25 |
Restrictive chest wall disease | 12 | 4 |
Obstructive lung disease | 12 | 8 |
Tidal volume (mL) | Obesity hypoventilation syndrome | 446 | 199 |
Neuromuscular disease | 338 | 340 |
Restrictive chest wall disease | 319 | 272 |
Obstructive lung disease | 619 | 360 |
Minute ventilation (L/min) | Obesity hypoventilation syndrome | 9.0 | 3.3 |
Neuromuscular disease | 6.0 | 4.6 |
Restrictive chest wall disease | 5.5 | 5.2 |
Obstructive lung disease | 11.3 | 6.5 |
Respiratory rate (bpm) | Obesity hypoventilation syndrome | 18 | 8 |
Neuromuscular disease | 17 | 11 |
Restrictive chest wall disease | 19 | 8 |
Obstructive lung disease | 17 | 1 |
Participant triggered breaths (%) | Obesity hypoventilation syndrome | 86 | 66 |
Neuromuscular disease | 55 | 91 |
Restrictive chest wall disease | 58 | 93 |
Obstructive lung disease | 13 | 77 |
Apnoea–Hypopnoea Index (events per hour) | Obesity hypoventilation syndrome | 1.7 | 21.7 |
Neuromuscular disease | 2.7 | 5.7 |
Restrictive chest wall disease | 1.4 | 1.9 |
Obstructive lung disease | 0.9 | 6.7 |